Prudential Financial’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17.3M | Sell |
54,623
-9,510
| -15% | -$2.24M | 0.02% | 482 |
|
|
2026
Q1 | $12.8M | Buy |
64,133
+18,497
| +41% | +$3.66M | 0.02% | 530 |
|
|
2025
Q4 | $8.63M | Buy |
45,636
+16,609
| +57% | +$3.19M | 0.01% | 677 |
|
|
2025
Q3 | $5.14M | Buy |
29,027
+660
| +2% | +$98.1K | 0.01% | 930 |
|
|
2025
Q2 | $3.22M | Sell |
28,367
-12,588
| -31% | -$1.35M | ﹤0.01% | 1142 |
|
|
2025
Q1 | $4.31M | Sell |
40,955
-62,040
| -60% | -$7.02M | 0.01% | 911 |
|
|
2024
Q4 | $11M | Buy |
102,995
+1,360
| +1% | +$154K | 0.02% | 569 |
|
|
2024
Q3 | $10.2M | Buy |
101,635
+83,715
| +467% | +$8.43M | 0.01% | 677 |
|
|
2024
Q2 | $1.51M | Sell |
17,920
-14,865
| -45% | -$1.18M | ﹤0.01% | 1588 |
|
|
2024
Q1 | $2.4M | Buy |
32,785
+13,830
| +73% | +$1.02M | ﹤0.01% | 1340 |
|
|
2023
Q4 | $1.35M | Sell |
18,955
-52,407
| -73% | -$3.09M | ﹤0.01% | 1662 |
|
|
2023
Q3 | $4.28M | Sell |
71,362
-5,470
| -7% | -$360K | 0.01% | 966 |
|
|
2023
Q2 | $5.54M | Buy |
76,832
+61,261
| +393% | +$4.6M | 0.01% | 855 |
|
|
2023
Q1 | $1.15M | Sell |
15,571
-2,750
| -15% | -$195K | ﹤0.01% | 1674 |
|
|
2022
Q4 | $1.22M | Sell |
18,321
-7,842
| -30% | -$510K | ﹤0.01% | 1605 |
|
|
2022
Q3 | $1.41M | Sell |
26,163
-1,290
| -5% | -$75.8K | ﹤0.01% | 1551 |
|
|
2022
Q2 | $1.53M | Sell |
27,453
-431
| -2% | -$24.5K | ﹤0.01% | 1555 |
|
|
2022
Q1 | $1.96M | Sell |
27,884
-465
| -2% | -$33.7K | ﹤0.01% | 1505 |
|
|
2021
Q4 | $2.79M | Sell |
28,349
-545
| -2% | -$50.3K | ﹤0.01% | 1351 |
|
|
2021
Q3 | $2.61M | Buy |
28,894
+9,727
| +51% | +$752K | ﹤0.01% | 1321 |
|
|
2021
Q2 | $1.57M | Sell |
19,167
-21,475
| -53% | -$1.79M | ﹤0.01% | 1595 |
|
|
2021
Q1 | $3.87M | Sell |
40,642
-117,257
| -74% | -$11.1M | 0.01% | 1138 |
|
|
2020
Q4 | $9.79M | Buy |
157,899
+6,098
| +4% | +$348K | 0.02% | 750 |
|
|
2020
Q3 | $9.03M | Buy |
151,801
+80,155
| +112% | +$5.47M | 0.02% | 699 |
|
|
2020
Q2 | $5M | Buy |
71,646
+51,249
| +251% | +$3.25M | 0.01% | 955 |
|
|
2020
Q1 | $925K | Sell |
20,397
-1,784
| -8% | -$101K | ﹤0.01% | 1718 |
|
|
2019
Q4 | $1.44M | Sell |
22,181
-9,600
| -30% | -$642K | ﹤0.01% | 1735 |
|
|
2019
Q3 | $1.97M | Sell |
31,781
-901
| -3% | -$56.6K | ﹤0.01% | 1587 |
|
|
2019
Q2 | $2.33M | Sell |
32,682
-784
| -2% | -$57.7K | ﹤0.01% | 1520 |
|
|
2019
Q1 | $2.62M | Sell |
33,466
-877
| -3% | -$66.4K | ﹤0.01% | 1460 |
|
|
2018
Q4 | $2.91M | Sell |
34,343
-136,979
| -80% | -$14.6M | 0.01% | 1335 |
|
|
2018
Q3 | $29.3M | Buy |
171,322
+44,820
| +35% | +$6.76M | 0.04% | 475 |
|
|
2018
Q2 | $16.3M | Buy |
126,502
+2,029
| +2% | +$226K | 0.02% | 727 |
|
|
2018
Q1 | $12.8M | Sell |
124,473
-1,980
| -2% | -$196K | 0.02% | 797 |
|
|
2017
Q4 | $10.8M | Buy |
126,453
+10,797
| +9% | +$936K | 0.01% | 884 |
|
|
2017
Q3 | $9.82M | Buy |
115,656
+37,899
| +49% | +$3M | 0.01% | 897 |
|
|
2017
Q2 | $5.89M | Sell |
77,757
-17,886
| -19% | -$1.25M | 0.01% | 1072 |
|
|
2017
Q1 | $6.32M | Sell |
95,643
-11,354
| -11% | -$747K | 0.01% | 1023 |
|
|
2016
Q4 | $6.78M | Sell |
106,997
-10,743
| -9% | -$678K | 0.01% | 991 |
|
|
2016
Q3 | $7.5M | Sell |
117,740
-32,782
| -22% | -$2.41M | 0.01% | 934 |
|
|
2016
Q2 | $11.2M | Buy |
150,522
+10,745
| +8% | +$797K | 0.02% | 774 |
|
|
2016
Q1 | $9.34M | Buy |
139,777
+4,433
| +3% | +$269K | 0.02% | 835 |
|
|
2015
Q4 | $9.15M | Sell |
135,344
-15,598
| -10% | -$963K | 0.02% | 828 |
|
|
2015
Q3 | $8.06M | Sell |
150,942
-11,012
| -7% | -$668K | 0.02% | 823 |
|
|
2015
Q2 | $10.2M | Sell |
161,954
-31,515
| -16% | -$1.72M | 0.02% | 810 |
|
|
2015
Q1 | $9.31M | Sell |
193,469
-119,199
| -38% | -$4.57M | 0.02% | 857 |
|
|
2014
Q4 | $10.4M | Sell |
312,668
-114,134
| -27% | -$3.71M | 0.02% | 707 |
|
|
2014
Q3 | $12.5M | Buy |
426,802
+40,357
| +10% | +$1.34M | 0.02% | 626 |
|
|
2014
Q2 | $15M | Buy |
386,445
+15,732
| +4% | +$638K | 0.03% | 595 |
|
|
2014
Q1 | $15.6M | Sell |
370,713
-57,548
| -13% | -$2.4M | 0.03% | 557 |
|
|
2013
Q4 | $14.1M | Buy |
428,261
+140,840
| +49% | +$4.59M | 0.03% | 580 |
|
|
2013
Q3 | $7.76M | Buy |
287,421
+62,998
| +28% | +$1.77M | 0.02% | 760 |
|
|
2013
Q2 | $5.24M | Buy |
+224,423
| New | +$4.04M | 0.01% | 880 |
|
Other funds holding LGND
JT
CAM
Prudential Financial's LGND Position: Q2 2026 in Review
Prudential Financial reduced its Ligand Pharmaceuticals (LGND) stake by 15% in Q2 2026, selling an estimated $2.24M and leaving 54,623 shares worth $17.3M. The position accounts for 0.02% of the portfolio, ranked #482.
Prudential Financial first reported a position in LGND in Q2 2013 and has held it in 53 quarters since. The position peaked at $29.3M in Q3 2018. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- Prudential Financial held 54,623 shares of Ligand Pharmaceuticals worth $17.3M as of Q2 2026.
- Prudential Financial sold 9,510 Ligand Pharmaceuticals shares in Q2 2026, an estimated $2.24M.
- Ligand Pharmaceuticals made up 0.02% of Prudential Financial's portfolio in Q2 2026, its #482 holding.
- Prudential Financial first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Prudential Financial's Ligand Pharmaceuticals position peaked at $29.3M in Q3 2018.
- 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.